Seres Therapeutics Inc (STU:1S9)
€ 0.738 -0.019 (-2.54%) Market Cap: 124.45 Mil Enterprise Value: 254.49 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 32/100

Seres Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 04:40PM GMT
Release Date Price: €22 (+2.80%)
Unidentified Analyst

Good morning, good afternoon, and good evening, depending on where you are. Thanks for joining us today. My name is [Ruben Vaxidov], and I'm a member of the JPMorgan team. It is my pleasure to introduce to you Eric Shaff, President and CEO of Seres. Eric, I'll turn it over to you now.

Eric D. Shaff
Seres Therapeutics, Inc. - President, CEO & Director

Well, good morning, everybody, and thank you to JPMorgan for bringing us together virtually today. We're very pleased to participate in this year's conference. I'll start by saying, I hope everyone on the line, is healthy and well. We look forward to speaking together in person. I'm optimistic that, that's becoming closer on the horizon. So on the session, I'm joined by members of the Seres team, and we will allocate time at the end for Q&A.

So I think it's fair to say that we're off to a particularly turbulent 2021, at least from a geopolitical point of view. And all of us are happy to turn the page on 2020, but as challenging as 2020 was for all of us, it also was a tipping point,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot